Skip to content
Services
Data Product Development and Engineering
AI Infrastructure & Engineering
Drug Discovery Computational Services
Research Environment
Consulting
Advisory across infrastructure, data & AI strategy
Data Sourcing & Partnerships
Find, access & connect the right data
Multimodal Data Integration
Unify imaging, omics & clinical data
Data Harmonization & Curation
Standardize & align data across sources
Data Pipelines & ETL
Reproducible ingestion & transformation
Data Automation & FAIRification
Automated, FAIR-compliant data flows
Where to start
Not sure your data is AI-ready?
A fixed-scope Data Journey assessment maps the gaps before you invest in modeling.
Scalable Data Infrastructure with Cloud
Cloud-native infrastructure that scales
AI-native phenotypic profiling platform
Image-analysis infrastructure for HCS
Agentic AI Workflows
Autonomous, orchestrated AI pipelines
AI-Ready Data Architecture
Architect data for AI from the start
Where to start
Not sure your data is AI-ready?
A fixed-scope Data Journey assessment maps the gaps before you invest in modeling.
Target Identification
Evidence-weighted target prioritization
Morphological Profiling
Phenotypic signatures linked to mechanism
Small Molecule Discovery
Multi-parameter compound prioritization
Biologics Discovery & Development
Developability-aware biologics design
Biomarkers
Biomarkers that survive validation
Clinical Research
HIPAA-aligned clinical data foundations
Discovery science
From a long list to a defensible shortlist.
We weight multimodal evidence into decisions your team can defend in review.
Scientific Applications & Data Visualisations
Custom scientific apps & dashboards
AI Model Development & Deployment
Build & deploy discovery-grade models
AI Agent Assistants for Scientists
AI copilots for research teams
Agentic AI Research Environment
An orchestrated agentic research stack
Discovery science
From a long list to a defensible shortlist.
We weight multimodal evidence into decisions your team can defend in review.
Consulting
Strategic guidance across infrastructure, data & AI.
AI readiness assessment
Clarify goals, gaps and priorities.
Architecture direction
Define the right foundation for scale.
Execution roadmap
Turn ideas into clear next steps.
Where to start
Go to Consulting
Explore the offer and book an assessment.
Technology
Ardigen phenAID
Phenotypic profiling platform
Ardigen Targets
Productized target identification
Ardigen Biologics
Binder design to optimized lead
Ardigen Biomarkers
Productized biomarker discovery
Ardigen ArdiOn – AI Engine
The AI engine behind our platforms
Platforms
AI-native technologies, built for discovery.
Productized platforms powered by Ardigen's proprietary AI engine and the AI-LAB loop.
Career
About us
Knowledge hub
Knowledge hub
Knowledge hub
News
Blog
Webinars
Case Studies
Publications
Posters
Topic
Target ID
Small Molecules
Clinical Drug Development
AI & ML
Bioinformatics
Software Engineering
Data Management
Bioinformatics Workflows
Phenotypic Screening
AI for Biologics
Search
Blog
Blog
7 January 2026
AI in Biotech: Lessons from 2025 and the Trends Shaping Drug Discovery in 2026
Blog
11 December 2025
The Applications of Morphological Profiling for Drug Discovery: The success stories
Blog
25 November 2025
Leading with purpose: Łukasz Nowak on building strong teams and scalable operations
Blog
18 November 2025
Lessons from the UK Biobank: Scaling AI Insights with Deep, Structured Data
Blog
14 November 2025
AI with impact: CTO Michał Warchoł on building tech that matters
Blog
7 November 2025
Leveraging Public Datasets for AI-Driven Discovery
Blog
5 November 2025
Challenges of AI in clinical trials and how to overcome them
Blog
21 October 2025
Adding Space to the Equation: How Spatial Context Enhances Drug Discovery
Blog
,
News
16 October 2025
Where Biology Meets Data: Key Takeaways from Festival of Biologics & BioTechX 2025
Blog
23 September 2025
Precision Trials: Using AI to Identify Responders
Blog
18 September 2025
Built on Trust, Driven by Impact: How Ardigen’s CCO – Livia Legg Sees the Future of Partnerships in AI & Biotech
Blog
28 August 2025
From Phenotypic Screening to AI-Powered Insight: How to Generate Data to Get the Most from Ardigen phenAID
Blog
21 August 2025
Can You Trust Your Model? Why Explainability Matters in AI-Driven Drug Discovery
Blog
14 August 2025
The AI-Biology Convergence: Designing the Next Generation of Biologics
Blog
16 July 2025
The Future of Drug Discovery: Integrating Phenotypic Data with Omics and AI
Blog
9 July 2025
What’s trending in European Biopharma? A look ahead
Blog
1 July 2025
Data dreams and drug design: What we learned at Discovery and Development Europe 2025
Blog
19 June 2025
Biologics 2.0 – From monoclonal antibodies to multispecific therapeutics
Page
1
Page
2
Page
3
Page
4
Page
5
10819